Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma - PubMed (original) (raw)
Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma
P H King et al. Ann Neurol. 1996 May.
Abstract
Hel-N1 and HuD are neuron-specific RNA-binding proteins that are antigenic targets of anti-Hu antibodies. Although expression of Hu antigens is most commonly seen in small-cell lung carcinoma, their exact identity (e.g., Hel-NI, Hel-N2, HuD, and HuC cannot be distinguished by immunological methods. Analysis of messenger RNA expression is needed for this distinction. Here we demonstrate that Hel-NI and Hel-N2 are expressed in small-cell lung carcinoma using reverse transcription-polymerase chain reaction.
Similar articles
- Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT, Smitt PS, Dalmau J, Posner JB. Manley GT, et al. Ann Neurol. 1995 Jul;38(1):102-10. doi: 10.1002/ana.410380117. Ann Neurol. 1995. PMID: 7541976 - Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D. Cairns P, et al. Cancer Res. 1997 Dec 1;57(23):5356-9. Cancer Res. 1997. PMID: 9393760 - Immune therapy for lung cancer: are we getting closer?
Bunn PA Jr. Bunn PA Jr. Am J Respir Cell Mol Biol. 1999 Jul;21(1):10-2. doi: 10.1165/ajrcmb.21.1.f153. Am J Respir Cell Mol Biol. 1999. PMID: 10385587 Review. No abstract available. - Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer.
Coulson JM. Coulson JM. Prog Brain Res. 2002;139:329-43. doi: 10.1016/s0079-6123(02)39028-9. Prog Brain Res. 2002. PMID: 12436947 Review. No abstract available.
Cited by
- Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression.
Antic D, Keene JD. Antic D, et al. Am J Hum Genet. 1997 Aug;61(2):273-8. doi: 10.1086/514866. Am J Hum Genet. 1997. PMID: 9311730 Free PMC article. Review. No abstract available. - Beta-blockers and glioma: a systematic review of preclinical studies and clinical results.
Tewarie IA, Senders JT, Hulsbergen AFC, Kremer S, Broekman MLD. Tewarie IA, et al. Neurosurg Rev. 2021 Apr;44(2):669-677. doi: 10.1007/s10143-020-01277-4. Epub 2020 Mar 14. Neurosurg Rev. 2021. PMID: 32172480 Free PMC article. - Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases.
Winkler AS, Dean A, Hu M, Gregson N, Chaudhuri KR. Winkler AS, et al. Clin Auton Res. 2001 Apr;11(2):115-8. doi: 10.1007/BF02322055. Clin Auton Res. 2001. PMID: 11570600 - Autoimmunity in paraneoplastic neurological syndromes.
Giometto B, Taraloto B, Graus F. Giometto B, et al. Brain Pathol. 1999 Apr;9(2):261-73. doi: 10.1111/j.1750-3639.1999.tb00225.x. Brain Pathol. 1999. PMID: 10219744 Free PMC article. Review. - Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.
Wang J, Guo Y, Chu H, Guan Y, Bi J, Wang B. Wang J, et al. Int J Mol Sci. 2013 May 10;14(5):10015-41. doi: 10.3390/ijms140510015. Int J Mol Sci. 2013. PMID: 23665903 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical